Business |Beauty
L'Oréal invests in Swiss longevity biotech company Timeline
Global beauty giant L'Oréal, through its venture capital fund Business Opportunities for L’Oréal Development (Bold), has invested in Timeline, a Swiss consumer health biotech company specialising in longevity. In a statement, Timeline confirmed that it raised 66 million US dollars in an “oversubscribed” Series D financing round, including...
loading...